|
Juvenile Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis (JRA) is an autoimmune
disorder causing
inflammation or swelling and stiffness in the joints, and may also
involve other parts of the body, including organs.
It is an arthritic condition that causes symptoms for more than six weeks
in children aged 16 or younger. There
are three types of JRA, depending upon the number of joints involved.
More than 300,000 children have some form of juvenile arthritis.
Your Care at
Ascend SpecialtyRx
Ascend SpecialtyRx
manages patients with Juvenile Rheumatoid Arthritis based on the most recent
Guidelines for the Treatment of Rheumatoid Arthritis from the
American College
of Rheumatology.
Our pharmacy maintains full availability of all needed
medications and medical supplies, and we offer around-the-clock emergency support
and patient counseling, as well as confidential, flexible and on-time delivery options.
Our expert pharmacy team works closely with each patient
and their healthcare providers to help ensure that patients take their medications
as prescribed, and monitor for any side effects from the medications.
We can also provide alternative therapy, whenever appropriate.
Common Drugs for the Treatment of Juvenile Rheumatoid
Arthritis
Enbrel
Special Considerations for Juvenile Rheumatoid Arthritis
Patients
Patients need additional monitoring and support to
maintain the safe and effective use of their medications.
For example, each month, our pharmacy team may remind patients of the importance
of notifying both their primary care doctor and rheumatologist if treated for an
infection with antibiotics. We might
also ask if the patient experienced any persistent fever; extreme or unusual fatigue; unexplained
or prolonged bruising or bleeding; black, bloody or tarry stools; fever or chills;
redness of the injection site or signs of infection such as sore throat or pale
skin.
Helpful Links
Ascend SpecialtyRx is not responsible for the content displayed in the following websites
American College
of Rheumatology
Arthritis Foundation
National
Institute of Arthritis
and Musculoskeletal and Skin Diseases
|